Clinical Trial

Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-06; most recent amendment 2026-01-15.
Status change: Recruiting → Completed 2026-01-15
Status change: Not Yet Recruiting → Recruiting 2025-09-10
Trial Details
NCT Number NCT07110441
Lead Sponsor Genfit
Conditions Acute-on-Chronic Liver Failure
Enrollment 52 participants
Start Date 2025-08-26
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-16